Market Tracker

05/24 7:34am ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.3075
Delayed Data
As of May 23
 +0.0075 / +2.50%
Today’s Change
0.21
Today|||52-Week Range
0.60
-26.84%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.30
Today’s open0.31
Day’s range0.30 - 0.31
Volume1,359,874
Average volume (3 months)1,556,236
Market cap$57.9M
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)-8.70%
Earnings growth (this year)+6.40%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
RNNRexahn Pharmaceutica...+0.01+4.82%
PZRXPhaseRx Inc+0.06+1.18%
CAPRCapricor Therapeutic...-0.03-1.01%
OREXOrexigen Therapeutic...+0.01+2.65%
Data as of 05/23/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$39.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
Chief Financial Officer, CAO &
Senior VP
Brandi L. Roberts
Corporate headquarters
San Diego, California

Forecasts